Literature DB >> 29481876

Recent advances in near-infrared light-responsive nanocarriers for cancer therapy.

Ankit Saneja1, Robin Kumar1, Divya Arora2, Sandeep Kumar3, Amulya K Panda1, Sundeep Jaglan4.   

Abstract

In recent years, research has focused on the development of smart nanocarriers that can respond to specific stimuli. Among the various stimuli-responsive platforms for cancer therapy, near-infrared (NIR) light (700-1000nm)-responsive nanocarriers have gained considerable interest because of their deeper tissue penetration capacity, precisely controlled drug release, and minimal damage towards normal tissues. In this review, we outline various therapeutic applications of NIR-responsive nanocarriers in drug delivery, photothermal therapy (PTT), photodynamic therapy (PDT), and bioimaging. We also highlight recent trends towards NIR-responsive combinatorial therapy and multistimuli-responsive nanocarriers for improving therapeutic outcomes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29481876     DOI： 10.1016/j.drudis.2018.02.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


  11 in total

1.  Iron(II) phthalocyanine Loaded and AS1411 Aptamer Targeting Nanoparticles: A Nanocomplex for Dual Modal Imaging and Photothermal Therapy of Breast Cancer.

Authors:  Lan Hao; Gengbiao Yuan; Yubei He; Mengzhu Wang; Ming Fu; Xun Yuan; Yuanli Luo; Bin Qiao; Jin Cao; Zhigang Wang
Journal:  Int J Nanomedicine       Date:  2020-08-11

2.  Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer.

Authors:  Rong Ma; Nuernisha Alifu; Zhong Du; Shuang Chen; Youqiang Heng; Jing Wang; Lijun Zhu; Cailing Ma; Xueliang Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-17

3.  CD44-Targeting Oxygen Self-Sufficient Nanoparticles for Enhanced Photodynamic Therapy Against Malignant Melanoma.

Authors:  Xiaoyang Hou; Yingkai Tao; Xinxin Li; Yanyu Pang; Chunsheng Yang; Guan Jiang; Yanqun Liu
Journal:  Int J Nanomedicine       Date:  2020-12-22

Review 4.  Triggering Immune System With Nanomaterials for Cancer Immunotherapy.

Authors:  Qiyan Li; Yulin Liu; Zihua Huang; Yajie Guo; Qingjiao Li
Journal:  Front Bioeng Biotechnol       Date:  2022-04-14

5.  Synthesis of novel cyclodextrin-modified reduced graphene oxide composites by a simple hydrothermal method.

Authors:  Qingli Huang; MingYan Li; LiLi Wang; Honghua Yuan; Meng Wang; Yongping Wu; Ting Li
Journal:  RSC Adv       Date:  2018-11-08       Impact factor: 3.361

Review 6.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

Review 7.  Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review).

Authors:  Sanjay Anand; Timothy A Chan; Tayyaba Hasan; Edward V Maytin
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-10

Review 8.  Nanotechnology for Cancer Therapy Based on Chemotherapy.

Authors:  Chen-Yang Zhao; Rui Cheng; Zhe Yang; Zhong-Min Tian
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

9.  NIR light-assisted phototherapies for bone-related diseases and bone tissue regeneration: A systematic review.

Authors:  Zhuqing Wan; Ping Zhang; Longwei Lv; Yongsheng Zhou
Journal:  Theranostics       Date:  2020-09-26       Impact factor: 11.556

10.  Near-Infrared Light-Responsive Shell-Crosslinked Micelles of Poly(d,l-lactide)-b-poly((furfuryl methacrylate)-co-(N-acryloylmorpholine)) Prepared by Diels-Alder Reaction for the Triggered Release of Doxorubicin.

Authors:  Sonyabapu Yadav; Kalyan Ramesh; Parveen Kumar; Sung-Han Jo; Seong Ii Yoo; Yeong-Soon Gal; Sang-Hyug Park; Kwon Taek Lim
Journal:  Materials (Basel)       Date:  2021-12-20       Impact factor: 3.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.